Webinar: Rapid identification and characterization of Affimers, a novel antibody mimetic using the iQue Screener platform

Affimers are small, stable proteins designed to be used in the place of antibodies as both research and diagnostic reagents, as well as biotherapeutics.

A combination of high throughput protein expression and the ability of the iQue Screener platform to perform high throughput multiplexed analysis enabled researchers at Avacta to move through phage display, candidate expression, and primary repertoire screening of affirmer libraries in as little as 8 weeks from acquiring target protein.

Complete the form below to watch this webinar and learn more.